Guest guest Posted June 10, 2007 Report Share Posted June 10, 2007 I was on the NORD website. National Organization for Rare Diseases. I saw this note in studies that were going on. Thought I would pass it along...... Debbie Co-Moderator Pulmonary Sarcoidosis People with state II or state III pulmonary sarcoidosis may be eligible to participate in a study to evaluate the effects of atorvastatin (Lipitor) as a possible treatment for this disease to replace or reduce the need for steroids. Sarcoidosis is a rare disease that results from inflammation and can occur in almost any organ, but most cases involve the lungs. For information on this study, call (TTY: 866 411-1010). You snooze, you lose. Get messages ASAP with AutoCheck in the all-new Yahoo! Mail Beta. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.